Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection
- PMID: 23505320
- PMCID: PMC3735930
- DOI: 10.1194/jlr.R026641
Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection
Abstract
Vitamin E is a naturally occurring fat-soluble antioxidant which has been proposed as a treatment for both primary and secondary protection against cardiovascular (CV) events. Promising data from observational epidemiological studies associating higher vitamin E dietary intake with lower risk of CV events have not been validated in randomized controlled clinical trials assessing the effect of vitamin E on CV outcomes. While the pendulum of medical opinion has swung to suggest that high dose vitamin E supplements have no place in the treatment and prevention of CV disease, new data is emerging that allows identification of a specific target population for this treatment, namely patients with diabetes mellitus and the haptoglobin genotype 2-2. This review details the scientific basis and clinical evidence related to the effect of vitamin E on CV outcomes, and the importance of proper patient selection in gaining therapeutic benefit from this intervention.
Keywords: cardiovascular outcomes; diabetes mellitus; haptoglobin.
Similar articles
-
Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.Curr Diab Rep. 2017 Jun;17(6):42. doi: 10.1007/s11892-017-0868-1. Curr Diab Rep. 2017. PMID: 28451949 Review.
-
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Eur J Intern Med. 2012 Oct;23(7):628-32. doi: 10.1016/j.ejim.2012.04.009. Epub 2012 May 14. Eur J Intern Med. 2012. PMID: 22939808 Free PMC article. Review.
-
Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.Clin Nutr. 2009 Oct;28(5):581-2. doi: 10.1016/j.clnu.2009.04.012. Epub 2009 May 22. Clin Nutr. 2009. PMID: 19464773
-
Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.Pharmacogenomics. 2008 Aug;9(8):989-91. doi: 10.2217/14622416.9.8.989. Pharmacogenomics. 2008. PMID: 18681772 No abstract available.
-
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1105-11. doi: 10.1586/14779072.5.6.1105. Expert Rev Cardiovasc Ther. 2007. PMID: 18035926 Review.
Cited by
-
Protective effects of paraoxonase-1, vitamin E and selenium, and oxidative stress index on the susceptibility of low density lipoprotein to oxidation in diabetic patients with/without coronary artery disease.Eur J Med Res. 2023 Aug 27;28(1):300. doi: 10.1186/s40001-023-01254-9. Eur J Med Res. 2023. PMID: 37635255 Free PMC article.
-
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging.Arch Toxicol. 2023 Oct;97(10):2499-2574. doi: 10.1007/s00204-023-03562-9. Epub 2023 Aug 19. Arch Toxicol. 2023. PMID: 37597078 Free PMC article. Review.
-
Antioxidant Green Factories: Toward Sustainable Production of Vitamin E in Plant In Vitro Cultures.ACS Omega. 2023 Jan 13;8(4):3586-3605. doi: 10.1021/acsomega.2c05819. eCollection 2023 Jan 31. ACS Omega. 2023. PMID: 36743063 Free PMC article. Review.
-
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review.Mar Drugs. 2022 May 24;20(6):342. doi: 10.3390/md20060342. Mar Drugs. 2022. PMID: 35736145 Free PMC article. Review.
-
The Biological Role of Vitamins in Athletes' Muscle, Heart and Microbiota.Int J Environ Res Public Health. 2022 Jan 23;19(3):1249. doi: 10.3390/ijerph19031249. Int J Environ Res Public Health. 2022. PMID: 35162272 Free PMC article. Review.
References
-
- Wang X., Quinn P. J. 1999. Vitamin E and its function in membranes. Prog. Lipid Res. 38: 309–336. - PubMed
-
- US Department of Agriculture, Agricultural Research Service. 2011. USDA National Nutrient Database for Standard Reference, Release 24. Accessed February 11, 2012. http://www.ars.usda.gov/ba/bhnrc/ndl.
-
- Mahoney C. W., Azzi A. 1988. Vitamin E inhibits protein kinase C activity. Biochem. Biophys. Res. Commun. 154: 694–697. - PubMed
-
- Boudreau R. T., Garduno R., Lin T. J. 2002. Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 277: 5322–5329. - PubMed
-
- Zingg J. M. 2007. Modulation of signal transduction by vitamin E. Mol. Aspects Med. 28: 481–506. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical